-
1Academic Journal
Συγγραφείς: A. A. Poromov, N. R. Makhmudova, I. N. Falynskova, E. A. Glubokova, N. P. Kartashova, I. T. Fedyakina, O. A. Svitich, I. A. Leneva, А. А. Поромов, Н. Р. Махмудова, И. Н. Фалынскова, Е. А. Глубокова, Н. П. Карташова, И. Т. Федякина, О. А. Свитич, И. А. Ленёва
Πηγή: Medical Immunology (Russia); Том 22, № 1 (2020); 99-110 ; Медицинская иммунология; Том 22, № 1 (2020); 99-110 ; 2313-741X ; 1563-0625
Θεματικοί όροι: цитокины, Staphylococcus aureus, secondary bacterial pneumonia, oseltamivr, cefuroxime, cytokine, вторичная бактериальная пневмония, осельтамивр, цефуроксим
Περιγραφή αρχείου: application/pdf
Relation: https://www.mimmun.ru/mimmun/article/view/1840/1227; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1840/5258; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1840/5259; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1840/5260; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1840/5262; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1840/5263; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1840/5264; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1840/5265; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1840/5266; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1840/5267; Ленева И.А., Леонова Е.И., Махмудова Н.Р., Фалынскова, И.Н. Федякина И.Т., Зверев В.В. Разработка экспериментальной модели сочетанной вирусно-бактериальной пневмонии // Вопросы вирусологии, 2015. T. 60, № 5. С. 27-31. [Leneva I.А., Leonova E.I., Маkhmudоvа N.R., Falynskova I.N., Fedyakina I.Т., Zverev V.V., Mikhailova N.A. Experimental model of secondary bacterial pneumonia after influenza. Voprosy virusologii = Problems of Virology, 2015, Vol. 60, no. 5, pp. 27-31. (In Russ.)]; Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B., 1995, Vol. 57, no. 1, pp. 289-300.; Caini S., Kroneman M., Wiegers T., El Guerche-Seblain C., Paget J. Clinical characteristics and severity of influenza infections by virus type, subtype, and lineage: A systematic literature review. Influenza Other Respir Viruses, 2018, Vol. 12, no. 6, pp. 780-792.; Fukuyama S., Kawaoka Y. The pathogenesis of influenza virus infections: the contributions of virus and host factors. Curr. Opin. Immunol., 2011, Vol. 23, no. 4, pp. 481-486.; Govorkova E.A., Leneva I.A., Goloubeva O.G., Bush K., Webster R.G. Comparison of efficacies of RWJ270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses. Antimicrob. Agents Chemother., 2001, Vol. 45, no. 10, pp. 2723-2732.; Harrington D. Linear rank tests in survival analysis. Encyclopedia of biostatistics, 2005. 6100 p.; Iverson A.R., Boyd K.L., McAuley J.L., Plano L.R., Hart M.E., McCullers J.A. Influenza virus primes mice for pneumonia from Staphylococcus aureus. J. Infect. Dis., 2011, Vol. 203, no. 6, pp. 880-888.; Kamal R.P., Alymova I.V., York I.A. Evolution and Virulence of Influenza A Virus Protein PB1-F2. Int. J. Mol. Sci., 2017, Vol. 19, no. 1, E96. doi:10.3390/ijms19010096.; Karlström Å., Boyd K.L., English B.K., McCullers J.A. Treatment with protein synthesis inhibitors improves outcomes from secondary bacterial pneumonia following influenza. J. Infect. Dis,. 2009, Vol. 199, no. 3, pp. 311-319.; Legand A., Briand S., Shindo N., Brooks W.A., de Jong M.D., Farrar J., Aguilera X., Hayden F.G. Addressing the public health burden of respiratory viruses: the Battle against Respiratory Viruses (BRaVe) Initiative. Future Virol., 2013, Vol. 8, no. 10, pp. 953-968.; Raj R.S., Bonney E.A., Phillippe M. Influenza, immune system, and pregnancy. Reprod. Sci., 2014, Vol. 21, no. 12, pp. 1434-1451.; Shindo N. Making progress on the WHO public health research agenda for influenza. Influenza Other Respir Viruses, 2013, Vol. 7, Suppl. 2, pp. 1-3.; Sladkova T., Kostolansky F. The role of cytokines in the immune response to influenza A virus infection. Acta Virol., 2006, Vol. 50, no. 3, pp. 151-162.; Smith M.W., Schmidt J.E., Rehg J.E., Orihuela C.J., McCullers J.A. Induction of pro- and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenza. Comp. Med., 2007, Vol. 57, no. 1, pp. 82-89.; Srivastava B., Błażejewska P., Hessmann M., Bruder D., Geffers R., Mauel S., Gruber A.D., Schughart K. Host genetic background strongly influences the response to influenza A virus infections. PLoS ONE, 2009, Vol. 4, no. 3, e4857. doi:10.1371/journal.pone.0004857.; Teijaro J.R. The role of cytokine responses during influenza virus pathogenesis and potential therapeutic options. Curr. Top. Microbiol. Immunol., 2015, Vol. 386, pp. 3-22.; van Reeth K. Cytokines in the pathogenesis of influenza. Vet. Microbiol., 2000, Vol. 74, no. 1-2, pp. 109-116.; https://www.mimmun.ru/mimmun/article/view/1840